{"id":41361,"date":"2025-11-07T00:14:00","date_gmt":"2025-11-07T00:14:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/4817520_CN17520_0"},"modified":"2025-11-07T00:14:00","modified_gmt":"2025-11-07T00:14:00","slug":"volpara-now-operates-under-lunit-brand-advancing-a-unified-vision-for-ai-cancer-intelligence","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=41361","title":{"rendered":"Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence"},"content":{"rendered":"<table name=\"logo_release\" border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2815594\/Lunit_Logo.jpg?p=medium600\" border=\"0\" alt title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><i>The&nbsp;rebranding marks the first phase of Lunit&#8217;s unified global identity, connecting breast health, AI detection, and precision oncology under one name.<\/i><\/p>\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">SEOUL, South Korea<\/span>, Nov. 7, 2025 \/PRNewswire\/ &#8212; Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and therapeutics, today announced that Volpara Health Technologies will now operate under the Lunit brand, introducing a unified global identity that merges their complementary strengths in breast health and AI innovation.<\/span><\/p>\n<p>This milestone builds on <a href=\"https:\/\/www.lunit.io\/en\/company\/news\/lunit-completes-acquisition-of-volpara-pioneering-next-level-of-ai-driven-cancer-care\" target=\"_blank\" rel=\"nofollow noopener\">Lunit&#8217;s 2024 acquisition of Volpara<\/a>, an important step that aligned both companies under one vision: to conquer cancer through AI.<\/p>\n<p>The integration builds a comprehensive ecosystem spanning risk prediction, early detection, imaging quality, and data-driven precision medicine, delivering greater value for clinicians, researchers, and patients worldwide. This positions Lunit among the few AI healthcare companies with a comprehensive cancer intelligence portfolio\u2014from breast health and screening to precision oncology\u2014serving over 10,000 healthcare providers across more than 65 countries.<\/p>\n<p>&#8220;By bringing Volpara under the Lunit brand, we&#8217;re uniting our technologies, teams, and mission to deliver a connected ecosystem that transforms how cancer is detected and treated worldwide,&#8221; said <span class=\"xn-person\">Brandon Suh<\/span>, CEO of Lunit. &#8220;This marks the start of a new era of collaboration and impact across every stage of cancer care.&#8221;<\/p>\n<p>To accelerate and enhance regional growth, Lunit is evolving its global operations under a unified structure. Lunit International (formerly Volpara Health Technologies) encompassing all former Volpara operations across the U.S., Oceania, <span class=\"xn-location\">Europe<\/span>, and <span class=\"xn-location\">Asia<\/span>, will lead Lunit&#8217;s business development and customer engagement efforts in these markets.<\/p>\n<p>In parallel, Lunit is transitioning part of its global sales organization into these regional hubs, allowing the <span class=\"xn-location\">Seoul<\/span> headquarters to focus on AI research, innovation, and new product development\u2014further sharpening its global focus and specialization.<\/p>\n<p>As part of this milestone, Lunit has launched a newly designed website (<a href=\"https:\/\/www.lunit.io\/en\" target=\"_blank\" rel=\"nofollow noopener\">www.lunit.io\/en<\/a>), reflecting its new digital identity and serving as a single digital gateway to its AI solutions, research, and corporate resources.<\/p>\n<p>&#8220;Our mission remains the same,&#8221; added Suh. &#8220;We aim to make AI the new standard for the entire cancer journey. We want every patient, regardless of geography or resources, to benefit from the same level of precision and insight, ensuring equitable access to life-saving diagnostics worldwide.&#8221;<\/p>\n<p><b>About Lunit<\/b><\/p>\n<p>Founded in 2013, Lunit (KRX: 328130) is a global leader on a mission to conquer cancer through AI. Our clinically validated solutions span medical imaging, breast health, and biomarker analysis\u2014empowering earlier detection, smarter treatment decisions, and more precise outcomes across the cancer care continuum.<\/p>\n<p>Following the integration of Volpara, Lunit now offers a comprehensive suite spanning risk prediction and early detection to precision oncology. Our FDA-cleared Lunit INSIGHT suite and breast health solutions support cancer screening in thousands of medical institutions worldwide, while Lunit SCOPE platform is used in research partnership with global pharma leaders for biomarker development and companion diagnostics.<\/p>\n<p>Trusted by over 10,000 sites in more than 65 countries, Lunit combines deep medical expertise with continuously evolving datasets to deliver measurable impact\u2014for patients, clinicians, and researchers alike.&nbsp;Headquartered in <span class=\"xn-location\">Seoul<\/span> with global offices, Lunit is driving the worldwide fight against cancer. Learn more at <a href=\"https:\/\/www.lunit.io\/en\" target=\"_blank\" rel=\"nofollow noopener\">lunit.io\/en<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The&nbsp;rebranding marks the first phase of Lunit&#8217;s unified global identity, connecting breast health, AI detection, and precision oncology under one name. SEOUL, South Korea, Nov. 7, 2025 \/PRNewswire\/ &#8212; Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and therapeutics, today announced that Volpara Health Technologies will now operate under the Lunit brand, [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-41361","post","type-post","status-publish","format-standard","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=41361\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence - My Blog\" \/>\n<meta property=\"og:description\" content=\"The&nbsp;rebranding marks the first phase of Lunit&#8217;s unified global identity, connecting breast health, AI detection, and precision oncology under one name. SEOUL, South Korea, Nov. 7, 2025 \/PRNewswire\/ &#8212; Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and therapeutics, today announced that Volpara Health Technologies will now operate under the Lunit brand, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=41361\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-07T00:14:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnasia.com\/media2\/2815594\/Lunit_Logo.jpg?p=medium600\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41361#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41361\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence\",\"datePublished\":\"2025-11-07T00:14:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41361\"},\"wordCount\":531,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41361#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2815594\\\/Lunit_Logo.jpg?p=medium600\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41361\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41361\",\"name\":\"Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41361#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41361#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2815594\\\/Lunit_Logo.jpg?p=medium600\",\"datePublished\":\"2025-11-07T00:14:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41361#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41361\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41361#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2815594\\\/Lunit_Logo.jpg?p=medium600\",\"contentUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2815594\\\/Lunit_Logo.jpg?p=medium600\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41361#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=41361","og_locale":"en_US","og_type":"article","og_title":"Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence - My Blog","og_description":"The&nbsp;rebranding marks the first phase of Lunit&#8217;s unified global identity, connecting breast health, AI detection, and precision oncology under one name. SEOUL, South Korea, Nov. 7, 2025 \/PRNewswire\/ &#8212; Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and therapeutics, today announced that Volpara Health Technologies will now operate under the Lunit brand, [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=41361","og_site_name":"My Blog","article_published_time":"2025-11-07T00:14:00+00:00","og_image":[{"url":"https:\/\/mma.prnasia.com\/media2\/2815594\/Lunit_Logo.jpg?p=medium600","type":"","width":"","height":""}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=41361#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=41361"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence","datePublished":"2025-11-07T00:14:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=41361"},"wordCount":531,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=41361#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/2815594\/Lunit_Logo.jpg?p=medium600","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=41361","url":"https:\/\/transmediavictoria.net.au\/?p=41361","name":"Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=41361#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=41361#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/2815594\/Lunit_Logo.jpg?p=medium600","datePublished":"2025-11-07T00:14:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=41361#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=41361"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=41361#primaryimage","url":"https:\/\/mma.prnasia.com\/media2\/2815594\/Lunit_Logo.jpg?p=medium600","contentUrl":"https:\/\/mma.prnasia.com\/media2\/2815594\/Lunit_Logo.jpg?p=medium600"},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=41361#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/41361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=41361"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/41361\/revisions"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=41361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=41361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=41361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}